BridgeBio price target raised to $49 from $48 at Scotiabank
Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner ...
Qantas Airways downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded Qantas Airways (QABSY) to Neutral from Outperform with a price target of A$9.30, up from A$8.40. Qantas ...
Down 50% In 8 Months, Is Crocs Stock A Buy Ahead Of Earnings?
Crocs stock has tumbled by nearly 50% since June 2024, underperforming industry peers and the broader stock market. Check out ...
KKR: Q4 Earnings, The Valuation Is Fair Compared To The Growth
KKR reported Q4 and full-year 2024 with higher-than-expected adjusted EPS of $1.32 but saw a stock drop due to disappointing ...